Achillion Pharmaceuticals is having a strong start in the pre-market hours today, and for good reason. The commpany has been issued a patent. As a result, the stock
Achillion Pharmaceuticals
Achillion Pharmaceuticals, Inc. (ACHN) will report its next earnings on May 1 – May ... Inc. and for the current quarter 7 analysts have projected that the stock could …
Oracle Corporation
One analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating on the company. Related Biotechnology, Pharmaceutical and Healthcare News Achillion Pharmaceuticals (ACHN) - Research …
Achillion Pharmaceuticals
Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) 3.4% HIGHER; announced that the U.S. Patent ... announced today that it has commenced a public offering of 4,300,000 shares of its common stock in connection with the forward sales …
consensus estimate
But it’s tough to see how biotech company Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) will lose out. Though ACHN stock has been volatile over the past couple of years, Achillion has several products in clinical trials, making ACHN
Investors in Achillion Pharmaceuticals Inc. (Symbol: ACHN) saw new options begin trading today, for the January 2015 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ACHN options chain for the …
In a separate filing, RA Capital disclosed that it sold 835,293 shares of Achillion Pharmaceuticals, Inc. …
Sells
One stock that might be an intriguing choice for investors right now is Achillion Pharmaceuticals, Inc. ACHN.This is because this security in the Medicine space is seeing solid earnings estimate revision activity, and is in great company …
Achillion stock dropped as the company announced earnings for the fourth quarter of 2014; Barclays rated the stock as Underweight Achillion Pharmaceutical, Inc. (NASDAQ:ACHN) stock has dropped almost 7.57% so far during trading as …
Looking back to 2 days ago, Achillion Pharmaceuticals Inc. (NASD: ACHN) priced a 12,000,000 share secondary stock offering at $10.25 per share. Buyers in that offering made a considerable investment into the company, expecting that …